Abstract

3628 Objective: Numerous studies and meta-analyses have shown significantly higher response rates of hepatic artery infusion (HAI) compared to systemic chemotherapy for liver metastasis from colorectal cancer (CRC). The combination of oxaliplatin with 5-FU and folinic acid can be safely administered as HAI. This final analysis of a phase I-/II-study evaluates toxicity and efficacy of this intraarterial regimen. Methods: Patients with histologically documented CRC with exclusive liver metastasis after surgery of the primary tumor were included. Pts received HAI with folinic acid (200mg/m2, 1 hour infusion) followed by 5-FU (600mg/m2, 2 hour infusion) on days 1 to 5, combined with oxaliplatin (62,5mg/m2, 4 hour infusion) on days 2 and 4. As a long term intrahepatic access, a chamber device was implanted into the groin connected to a catheter radiologically placed into the hepatic artery. Supportive treatment consisted of a 5-HT3-receptor antagonist p.o., paracetamol 1000mg p.o. and a H2-antagonist. Furthermore dexamethasone 8mg p.o. was given 30 min prior and 2 hours after application of oxaliplatin. Results: Twenty-four pts were enrolled (66% colon cancer, 34% rectum cancer). Median age was 62 years (range 34–77), ECOG PS≤2. They were either chemonaive (n=14) or had received an adjuvant treatment ≥6 months before start of study (n=10). Median number of HAI cycles was 7 (range 2–26). WHO grade 3/4-toxicities included leucopenia (19%), thrombocytopenia (10%), hyperbilirubinemia (10%), diarrhea (5%), and abdominal pain (10%). The overall response rate was 70,8%. Complete remission was observed in 5 pts (20,8%), PR in 12 pts (50%), 3 pts obtained SD (12,5%), and 4 had PD (16,7%). Median TTP was 8,8 months. Median overall survival reached 25,5 months. Four years after start of treatment, 5 pts (20,8%) were alive. Two pts (8,3%) had obtained partial liver resection, and 2 pts (8,3%) were treated with radiofrequency ablation after remission had been achieved by the intrahepatic chemotherapy. Conclusion: This final analysis indicates that HAI of 5-FU, folinic acid and oxaliplatin is safe and highly effective in patients with exclusive liver metastasis from CRC. No significant financial relationships to disclose.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call